GlycoMimetics Inc. (NASDAQ: GLYC) stock closed at 1.26 per share at the end of the most recent trading day (a 0.8% change compared to the prior day closing price) with a volume of 469.62K shares and market capitalization of 80.95M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 57 people. GlycoMimetics Inc. CEO is Rachel K. King.

The one-year performance of GlycoMimetics Inc. stock is 9.65%, while year-to-date (YTD) performance is -58.42%. GLYC stock has a five-year performance of -92.24%. Its 52-week range is between 0.51 and 4.16, which gives GLYC stock a 52-week price range ratio of 20.55%

GlycoMimetics Inc. currently has a PE ratio of -2.80, a price-to-book (PB) ratio of 3.08, a price-to-sale (PS) ratio of 1 943.18, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -73.09%, a ROC of -73.24% and a ROE of -82.92%. The company’s profit margin is -%, its EBITDA margin is -58 282.60%, and its revenue ttm is $75.00 Thousand , which makes it $0.00 revenue per share.

Of the last four earnings reports from GlycoMimetics Inc., there were 3 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.16 for the next earnings report. GlycoMimetics Inc.’s next earnings report date is 27th Apr 2023.

The consensus rating of Wall Street analysts for GlycoMimetics Inc. is Strong Buy (1), with a target price of $8, which is +534.92% compared to the current price. The earnings rating for GlycoMimetics Inc. stock is Strong Buy (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

GlycoMimetics Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

GlycoMimetics Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 20.67, ATR14 : 0.15, CCI20 : -166.72, Chaikin Money Flow : -0.09, MACD : -0.19, Money Flow Index : 23.57, ROC : -15.44, RSI : 34.36, STOCH (14,3) : 22.50, STOCH RSI : 0.12, UO : 48.47, Williams %R : -77.50), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of GlycoMimetics Inc. in the last 12-months were: Armand Girard (Buy at a value of $6 825), Brian M. Hahn (Buy at a value of $21 200), Daniel M. Junius (Buy at a value of $37 400), Edwin Rock (Buy at a value of $556 500), Harout Semerjian (Buy at a value of $32 250), John L. Magnani (Buy at a value of $52 703), Sandell D Scott (Sold 4 050 149 shares of value $12 670 400 ), Scott Koenig (Option Excercise at a value of $26 775), Timothy R. Pearson (Buy at a value of $25 026)